XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:    
Research and development $ 12,705,000 $ 3,951,000
Acquired in-process research and development 80,538,000 0
General and administrative 14,724,000 3,297,000
Transaction costs 5,765,000 0
Total operating expenses 113,732,000 7,248,000
Loss from operations (113,732,000) (7,248,000)
Other expenses, net:    
Loss on sale of NTN assets (9,648,000) 0
Other income (expense), net 899,000 (43,000)
Total other expenses, net (8,749,000) (43,000)
Loss before income taxes (122,481,000) (7,291,000)
Provision for income taxes (64,000) 0
Net loss (122,545,000) (7,291,000)
Series A preferred stock dividend (16,000) 0
Net loss attributable to common stockholders $ (122,561,000) $ (7,291,000)
Net loss per common share - basic (in dollars per share) $ (2.83) $ (0.41)
Net loss per common share - diluted (in dollars per share) $ (2.83) $ (0.41)
Weighted average number of shares outstanding - basic (in shares) 43,306 17,588
Weighted average number of shares outstanding - diluted (in shares) 43,306 17,588